Skip to main content

SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) is a SARS-CoV-2 Fragment protein, in the 1 to 1213 aa range, expressed in Baculovirus infected insect, with =90% purity, < 1 EU/µg endotoxin level and suitable for SDS-PAGE, FuncS.

Be the first to review this product! Submit a review

Images

SDS-PAGE - SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) (AB289620), expandable thumbnail
  • ELISA - SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) (AB289620), expandable thumbnail

Key facts

Purity
=90% SDS-PAGE
Endotoxin level
< 1 EU/µg
Expression system
Baculovirus infected insect cells
Tags
His tag C-Terminus
Applications
SDS-PAGE, FuncS
Biologically active
Yes

Reactivity data

Application
SDS-PAGE
Reactivity
Reacts
Dilution info
-
Notes

-

Application
FuncS
Reactivity
Reacts
Dilution info
-
Notes

-

Target data

Function

Spike protein S1. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed:32142651, PubMed:32155444, PubMed:33607086). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed:34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis leading to fusion of the virion membrane with the host endosomal membrane (PubMed:32075877, PubMed:32221306). Alternatively, may use NRP1/NRP2 (PubMed:33082294, PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The use of NRP1/NRP2 receptors may explain the tropism of the virus in human olfactory epithelial cells, which express these molecules at high levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S contains three hinges, giving the head unexpected orientational freedom (PubMed:32817270). Spike protein S2. Precursor of the fusion protein processed in the biosynthesis of the S protein and the formation of virus particle. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains two viral fusion peptides that are unmasked after cleavage. The S2/S2' cleavage occurs during virus entry at the cell membrane by host TMPRSS2 (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616). In either case, this triggers an extensive and irreversible conformational change leading to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes. Spike protein S2'. Subunit of the fusion protein that is processed upon entry into the host cell. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains a viral fusion peptide that is unmasked after S2 cleavage. This cleavage can occur at the cell membrane by host TMPRSS2 or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616). In either case, this triggers an extensive and irreversible conformational change that leads to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.

Alternative names

Recommended products

SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) is a SARS-CoV-2 Fragment protein, in the 1 to 1213 aa range, expressed in Baculovirus infected insect, with =90% purity, < 1 EU/µg endotoxin level and suitable for SDS-PAGE, FuncS.

Key facts

Purity
=90% SDS-PAGE
Endotoxin level
< 1 EU/µg
Expression system
Baculovirus infected insect cells
Applications
SDS-PAGE, FuncS
Biological activity
Immobilized ACE2 Protein, Human, Recombinant (mFc Tag) at 2 μg/mL (100 μL/well) can bind ab289620, the EC50 of ab289620 is 100-700 ng/mL.
Accession
P0DTC2-1
Animal free
No
Species
SARS-CoV-2
Concentration
Loading...
Storage buffer

pH: 8
Constituents: 10% Glycerol (glycerin, glycerine), 5% Mannitol, 5% Trehalose, 1.753% Sodium chloride, 0.242% Tris, 0.01% Tween 80

Sequence info

Amino acid sequence

Accession
P0DTC2
Protein length
Fragment
Predicted molecular weight
134.4 kDa
Amino acids
1 to 1213
Nature
Recombinant
Tags
His tag C-Terminus

Specifications

Form
Lyophilized
Additional notes

His-tag affinity purified

General info

Function

Spike protein S1

Sequence similarities

Belongs to the betacoronaviruses spike protein family.

Post-translational modifications

The cytoplasmic Cys-rich domain is palmitoylated. Palmitoylated spike proteins drive the formation of localized ordered cholesterol and sphingo-lipid-rich lipid nanodomains in the early Golgi, where viral budding occurs.

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

This product is an active protein and may elicit a biological response in vivo, handle with caution.

Notes

The mutations were identified in the SARS-CoV-2 variant (known as 20C/501Y.V2 or B.1.351 lineage) which emerged in South Africa.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The SARS-CoV-2 Spike Ectodomain often referred to simply as the spike protein is a critical component of the virus that enables entry into host cells. This glycoprotein is about 180 kDa and is prominently expressed on the viral surface. The spike protein is marked by significant regions including the S1 and S2 subunits which facilitate the binding and fusion processes necessary for viral entry into human cells. Variants like the D614G and notable mutations such as H69 deletion or D80A affect its structure. The spike protein is central to vaccine design due to its role in mediating infection.

Biological function summary

The spike protein is critical for the interaction with the host angiotensin-converting enzyme 2 (ACE2) serving as an important component in the viral entry into human cells. It forms a trimeric complex important for mediating the fusion of the viral membrane with the host cell's membrane. Structural changes such as deletions in the HV69-70 region or mutations like D80A can impact the protein's functionality and viral virulence. Therefore understanding these mutations has implications for infection control efforts.

Pathways

The spike protein plays a central role in the viral invasion pathway that starts with the recognition of the ACE2 receptor on the host cell. This pathway integrates the spike protein's functionality with other viral and host proteins leading to cell entry and subsequent viral replication. The renin-angiotensin system (RAS) is closely related given the ACE2 receptor's involvement in this physiological pathway highlighting the importance of these interactions in both viral pathology and host response.

Associated diseases and disorders

The spike protein is instrumental in the pathogenesis of COVID-19 and related respiratory disorders. Its interaction with ACE2 is central in determining the infection's severity and transmission potential. Additionally the spike protein's structural changes such as HV69-70 deletions or D80A mutations can alter the disease manifestation by affecting how the immune system recognizes the virus. This structural variability potentially impacts vaccine efficacy and therapeutic antibody effectiveness complicating disease management and treatment strategies.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • SDS-PAGE - SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) (ab289620), expandable thumbnail

    SDS-PAGE - SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) (ab289620)

    SDS PAGE analysis of ab289620

  • ELISA - SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) (ab289620), expandable thumbnail

    ELISA - SARS-CoV-2 Spike S1+S2 (mutated D80A + K417N + E484K + N501Y + D614G + A701V) protein (Active) (ab289620)

    Immobilized ACE2 Protein, Human, Recombinant (mFc Tag) at 2 μg/mL (100 μL/well) can bind ab289620, the EC50 for ab289620 is 100-700 ng/mL.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com